WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura Lee SandlerCOO2026-09-011,000$91.05
$91.05kSell
Laura Lee SandlerCOO2026-09-014,000$92.01
$368.05kSell
Lawrence Otto KleinCEO2026-09-0175,000$7.80
$585.00kBuy
Lawrence Otto KleinCEO2026-09-016,604$90.79
$599.56kSell
Lawrence Otto KleinCEO2026-09-0163,596$91.90
$5.84MSell
Lawrence Otto KleinCEO2026-09-014,800$92.44
$443.69kSell
Laura Lee SandlerCOO2026-09-015,000$7.80
$39.00kBuy
Joana GoncalvesMed2026-08-173,500$7.80
$27.30kBuy
Joana GoncalvesMed2026-08-17900$109.65
$98.69kSell
Joana GoncalvesMed2026-08-173,500$6.84
$23.94kBuy

1 of 13

ORKA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David M. Mott15.44%10,221,465$944.26MInsider
Peter J. Barris15.44%10,221,465$944.26MInsider
Forest Baskett15.44%10,221,465$944.26MInsider
Harry R. Weller15.44%10,221,465$944.26MInsider
Anthony A. Florence Jr.15.44%10,221,465$944.26MInsider
Ravi Viswanathan15.44%10,221,465$944.26MInsider
Peter W. Sonsini15.44%10,221,465$944.26MInsider
Krishna Kittu Kolluri15.44%10,221,465$944.26MInsider
Scott D. Sandell15.44%10,221,465$944.26MInsider
Joshua Makower15.44%10,221,465$944.26MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA0.05%99.95%Net SellingNet Selling
SRRK0.11%67.14%Net BuyingNet Selling
MIRM0.11%81.25%Net BuyingNet Selling
TVTX0.11%61.61%Net SellingNet Selling
CGON0.11%16.34%Net BuyingNet Buying
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 0.11% institutional shareholders, 232.47% Oruka Therapeutics insiders, and 0.00% retail investors. David M. Mott is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 15.44% of the company. David M. Mott's Oruka Therapeutics shares are currently valued at $980.55M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.